DE60131416D1 - Chirale fluorochinolizinon arginine salze - Google Patents
Chirale fluorochinolizinon arginine salzeInfo
- Publication number
- DE60131416D1 DE60131416D1 DE60131416T DE60131416T DE60131416D1 DE 60131416 D1 DE60131416 D1 DE 60131416D1 DE 60131416 T DE60131416 T DE 60131416T DE 60131416 T DE60131416 T DE 60131416T DE 60131416 D1 DE60131416 D1 DE 60131416D1
- Authority
- DE
- Germany
- Prior art keywords
- arginine salt
- fluorochinolicinine
- chiral
- salt forms
- hydroxypiperidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001483 arginine derivatives Chemical class 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/566,875 US7247642B2 (en) | 1999-05-07 | 2000-05-08 | Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
| US566875 | 2000-05-08 | ||
| US09/640,947 US6750224B1 (en) | 1999-05-07 | 2000-08-17 | Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
| US640947 | 2000-08-17 | ||
| IN0000111 | 2000-11-22 | ||
| WOPCT/IN00/00111 | 2000-11-22 | ||
| US802793 | 2001-03-09 | ||
| US09/802,793 US6514986B2 (en) | 2000-11-22 | 2001-03-09 | Chiral fluoroquinolone arginine salt forms |
| PCT/IN2001/000097 WO2001085095A2 (en) | 2000-05-08 | 2001-05-03 | Chiral fluoroquinolizinone arginine salt forms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60131416D1 true DE60131416D1 (de) | 2007-12-27 |
| DE60131416T2 DE60131416T2 (de) | 2008-09-18 |
Family
ID=56290141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60131416T Expired - Fee Related DE60131416T2 (de) | 2000-05-08 | 2001-05-03 | Chirale fluochinolon-argininsalzformen |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1311506B1 (de) |
| AT (1) | ATE378335T1 (de) |
| AU (1) | AU7866601A (de) |
| CA (1) | CA2403264A1 (de) |
| DE (1) | DE60131416T2 (de) |
| WO (1) | WO2001085095A2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6608078B2 (en) | 2000-05-08 | 2003-08-19 | Wockhardt Limited | Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment |
| US7098219B2 (en) | 2000-08-01 | 2006-08-29 | Wockhart Limited | Inhibitors of cellular efflux pumps of microbes |
| US6964966B2 (en) | 2001-04-25 | 2005-11-15 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| US6878713B2 (en) | 2001-04-25 | 2005-04-12 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| EP1918289A3 (de) | 2002-05-28 | 2009-08-19 | Wockhardt Limited | Kristalline Form eines Fluorchinolon-Argininsalzes |
| WO2003099815A1 (en) * | 2002-05-28 | 2003-12-04 | Wockhardt Limited | Crystalline fluoroquinolone arginine salt form |
| US20040176337A1 (en) * | 2002-12-31 | 2004-09-09 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid-containing compositions |
| BR0318460A (pt) | 2003-09-04 | 2006-09-12 | Wockhardt Ltd | sal de arginina de ácido benzoquinolizina-2-carboxìlico tetrahidratado |
| WO2005026145A2 (en) * | 2003-09-12 | 2005-03-24 | Warner-Lambert Company Llc | Quinolone antibacterial agents |
| EP2536408A1 (de) * | 2010-02-16 | 2012-12-26 | Wockhardt Research Centre | Effluxpumpenhemmer |
| CN102532131B (zh) * | 2010-12-22 | 2015-09-16 | 南京长澳医药科技有限公司 | 一种s-(-)-那氟沙星-l-精氨酸盐的制备方法 |
| WO2013046061A1 (en) * | 2011-09-28 | 2013-04-04 | Wockhardt Limited | Pures-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,-5h-benzo[i,j]quinolizine-2- carboxylic acid l-arginine salt tetrahydrate and a process for its preparation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO156828C (no) * | 1980-11-10 | 1987-12-02 | Otsuka Pharma Co Ltd | Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser. |
| US7247642B2 (en) * | 1999-05-07 | 2007-07-24 | Wockhardt Limited | Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
-
2001
- 2001-05-03 DE DE60131416T patent/DE60131416T2/de not_active Expired - Fee Related
- 2001-05-03 AU AU78666/01A patent/AU7866601A/en not_active Abandoned
- 2001-05-03 EP EP01956751A patent/EP1311506B1/de not_active Expired - Lifetime
- 2001-05-03 AT AT01956751T patent/ATE378335T1/de not_active IP Right Cessation
- 2001-05-03 CA CA002403264A patent/CA2403264A1/en not_active Abandoned
- 2001-05-03 WO PCT/IN2001/000097 patent/WO2001085095A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE378335T1 (de) | 2007-11-15 |
| DE60131416T2 (de) | 2008-09-18 |
| EP1311506B1 (de) | 2007-11-14 |
| WO2001085095A2 (en) | 2001-11-15 |
| WO2001085095A3 (en) | 2002-10-03 |
| WO2001085095B1 (en) | 2002-12-27 |
| AU7866601A (en) | 2001-11-20 |
| CA2403264A1 (en) | 2001-11-15 |
| EP1311506A2 (de) | 2003-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03005464A (es) | Agentes antivirales. | |
| BG106095A (bg) | Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| DE60140814D1 (de) | N-phenyl-2-pyrimidine-amine derivatives | |
| BG66094B1 (bg) | Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства | |
| BR0012590A (pt) | Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central | |
| EP1291362A4 (de) | Komplex aus folsäure und polysacchariden, dessen herstellung sowie diesen komplex als aktiven bestandteil enthaltende pharmazeutische zusammensetzung | |
| WO2005000232A3 (en) | Six membered amino-amide derivatives as angiogenesis inhibitors | |
| DE60131416D1 (de) | Chirale fluorochinolizinon arginine salze | |
| EA200400086A1 (ru) | Новые производные оксазолидинонов в качестве антибактериальных агентов | |
| SE0102440D0 (sv) | New compound | |
| SE0401655D0 (sv) | New compounds | |
| ATE253359T1 (de) | Antithrombotische mittel | |
| TR200200473T2 (tr) | Rar selektif retinoid agonistleri. | |
| DK1660495T3 (da) | Benzoquinolizin-2-carboxylsyreargininsalt,tetrahydrat | |
| DE69927997D1 (de) | Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung | |
| DE69828522D1 (de) | Antithrombotische mittel | |
| ATE325809T1 (de) | Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure | |
| SE9900190D0 (sv) | New compounds | |
| PT1411956E (pt) | Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih | |
| EP1918289A3 (de) | Kristalline Form eines Fluorchinolon-Argininsalzes | |
| DE60008430D1 (de) | Verbindungen mit antithrombotischer wirkung | |
| SE0202311D0 (sv) | Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment | |
| DE60208541D1 (de) | Antibakterielle mittel | |
| DE60227424D1 (de) | Kristalline form eines fluorchinolon-argininsalzes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |